AtriCure Q1 2026 revenue $141.2M (+14.3%); net income $0.1M; adj. EBITDA $17.1M

AtriCure, Inc.

2026-Q1 EPS reported $0.00 revenue$141,249,000

Worldwide revenue $141.2M (+14.3% YoY); U.S. $116.2M (+14.9%), international $25.0M (+11.5%).
Gross margin 77.4% (+246 bps); income from operations $0.5M vs loss of $6.0M in Q1 2025.
Net income $0.1M; EPS breakeven at $0.00 (vs net loss $0.14 in Q1 2025).
Adjusted EBITDA $17.1M, up 95% from $8.8M in Q1 2025.
No GAAP-to-non-GAAP reconciling items; adjusted EPS also $0.00.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

AtriCure, Inc. reported first quarter ended March 31, 2026 results: revenue $141.2 million, net income $0.1 million, EPS breakeven at $0.00.

Period: first quarter ended March 31, 2026
Revenue: $141.2 million
Net income: $0.1 million
EPS: breakeven at $0.00
Result: reported results

Exact text from the filing

or document. --- EX-99.1 (EX-99.1) --- For immediate release May 5, 2026 AtriCure Reports First Quarter 2026 Financial Results • First Quarter 2026 worldwide revenue of $141.2 million, an increase of 14.3% year over year • First Quarter 2026 profitability improved, with net income of $0.1 million and adjusted EBITDA of $17.1 million • U.S. revenue growth

View on SEC.gov

Browse all earnings releases →

AtriCure, Inc. filing history →

Source: SEC EDGAR

accession 0001323885-26-000018

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.